<DOC>
	<DOC>NCT02794025</DOC>
	<brief_summary>The purpose of this study was to investigate the effect of esmolol on hemodynamic parameters,tissue perfusion and the clinical prognosis of patients with severe sepsis</brief_summary>
	<brief_title>The Effect of Esmolol on Clinical Prognosis of Patients With Severe Sepsis</brief_title>
	<detailed_description>enrollment:151 patients Inclusion criteria: (1) age &gt; 18 years; (2) severe sepsis (acute organ dysfunction secondary to infection )diagnosis according to Campaign to Save Septic Patients: 2008 Treatment Guidelines for Severe Sepsis and Septic Shock, who (3) mechanical ventilation via endotracheal intubation with a tidal volume of 6 mL/kg; and (4) satisfactory sedation and analgesic treatment, with HR &gt; 100 bpm.</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Esmolol</mesh_term>
	<criteria>age &gt; 18 years; severe sepsis (acute organ dysfunction secondary to infection )diagnosis according to Campaign to Save Septic Patients: 2008 Treatment Guidelines for Severe Sepsis and Septic Shock, mechanical ventilation via endotracheal intubation with a tidal volume of 6 mL/kg; satisfactory sedation and analgesic treatment, with HR &gt; 100 bpm. preexisting cardiac dysfunction, valvular heart disease, highdegree atrioventricular block; acute or chronic pulmonary heart disease; a history of serious asthma; chronic renal insufficiency; cancer, autoimmune diseases, or contraindications for placement of deep venous catheter; insulindependent diabetes.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>